Bio-Path Hldgs Stock (NASDAQ: BPTH) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 4.06K / 336.84K |
Day Range | - - - |
52 Wk Range | 0.91 - 21.60 |
Market Cap | $2.48M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 1.81% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Bio-Path Hldgs (NASDAQ:BPTH) through any online brokerage.
Other companies in Bio-Path Hldgs’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
Bio-Path Hldgs has a consensus price target of $23.00.
The stock price for Bio-Path Hldgs (NASDAQ: BPTH) is $0.97 last updated September 19, 2024 at 6:09 AM EDT.
There are no upcoming dividends for Bio-Path Hldgs.
Bio-Path Hldgs’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
There is no upcoming split for Bio-Path Hldgs.
Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.